with higher homocysteine plasma levels in the subgroup of patients (p = 0.013, 1-way ANOVA). Conclusion: These data support the hypothesis that alterations in homocysteine metabolism and an unfavorable blood lipoprotein profile may have a common genetic basis. Such conditions may be relevant for studies investigating independent risk factors for vascular disease.
Introduction
Hyperhomocysteinemia and altered plasma lipid levels are considered to be independent risk factors for the development of vascular disease. Recent studies, however, have suggested a relation between homocysteine metabolism and lipid metabolism [1] . Patients with severe hyperhomocysteinemia due to a cystathionine ␤ -synthase (CBS) deficiency (OMIM 236200) develop a wide range of symptoms including arteriosclerosis and hepatic steatosis (fatty degeneration of liver tissue) [2] . CBSdeficient mice also show hepatic steatosis associated with an abnormal lipid metabolism [3] . A correlation of plasma homocysteine levels with the blood lipid profile was found in patients with moderate hyperhomocysteinemia [4, 5] as well as in animal models [6, 7] and cell cultures [8] . In wild-type and APOE-deficient mice, a depletion of dietary folate (a cofactor of homocysteine metabolism) leads to increased levels of serum and liver cholesterol and an altered expression profile of the cholesterol biosynthesis pathway [9] . A meta-analysis by Sharma et al. [10] demonstrated 112 genes that are modulated by elevated levels of homocysteine. Mapping these genes to their pathways suggested that hyperhomocysteinemia might induce arteriosclerosis by directly affecting lipid metabolism. To test for a possible interaction between homocysteine and plasma lipid metabolism on the genetic level, we examined 7 functionally relevant genetic variants of homocysteine metabolism for a possible influence on the plasma lipid profile.
Materials and Methods

Patients and Study Participants
Overall, 504 individuals were included in this study. We recruited 135 consecutive Caucasian patients (mean age 64.2 8 8.8 years, 27.4% female) from the ultrasound division of the Department of Neurology of the University of Bonn, Germany. Patients had been referred due to cerebrovascular, cardiovascular, or peripheral vascular disease and had been diagnosed with at least unilateral 30% carotid stenosis. Additionally, we recruited the patients' spouses (n = 100; mean age 61.8 8 8.7 years, 79% female) and their offspring (n = 269, mean age 35.9 8 8.4 years, 53% female). Personal data, ultrasonic findings, medical history, tobacco smoking, and laboratory findings including fasting blood lipid profile parameters were determined as described previously [11] . Of the enrolled subjects, 17.9% received medication with an HMGCoA reductase inhibitor (statin). Patients with abnormal renal parameters or an intake of (multi)vitamin preparations were excluded from the study. Data about physical activity or lifestyle were not available. The study was approved by the local ethics committee, and all participants gave their written informed consent.
Genotyping
Genomic DNA prepared from peripheral leukocytes was used for genotyping by PCR amplification and restriction analysis of 7 genetic variants of homocysteine metabolism including the intronic deletion dihydrofolate reductase c.594 + 59del19bp (affecting the transcript level; GenBank NM_000791.3); the splice alteration CBS c.844_855ins68 (affecting the transcript level; GenBank S78267.1); the missense mutations (i.e. leading to amino acid exchanges) methionine synthase c.2756A ] G (p.D919G; rs1805087), methylenetetrahydrofolate reductase (MTHFR) c.677C ] T (p.A222V; rs1801133), and c.1298A ] C (p.E429A; rs1801131); reduced folate carrier 1 c.80G ] A (p.R27H; rs1051266), and transcobalamin 2 (Tc2) c.776C ] G (p.P259R; rs1801198) [12] .
Statistics
Deviations from the Hardy-Weinberg equilibrium were separately analyzed using a 2 goodness-of-fit test comparing observed and expected numbers for each genetic variant ( ␣ = 0.05).
As some of the analyzed variables were not normally distributed, a log transformation was carried out for statistical testing. Linear regression with lipoprotein(a), total cholesterol (TC), LDL, HDL, and triglyceride (TG) fasting plasma levels as dependent variables and age, gender, statin therapy, smoking, family relationship, and the 7 examined polymorphisms as independent variables was utilized to test for independent associations of the polymorphisms with the plasma lipid profile. Due to multiple testing, the threshold was defined as ␣ = 0.01 in accordance with the Bonferroni correction. Additionally, linear regression was used to analyze the association of homocysteine levels with the 7 polymorphisms. One-way ANOVA was used for univariate descriptive analysis of the association of genotypes with plasma lipoprotein parameters.
Results
The distribution of genotypes did not deviate from the 
Discussion
In our study sample, the G allele of Tc2 c.776C ] G was associated with an unfavorable blood lipoprotein profile, i.e. with higher LDL plasma levels, lower HDL plasma levels, higher triglyceride plasma levels, and higher TC levels, for trend. Additionally, MTHFR c.677C ] T correlated with HDL plasma levels. As this polymorphism is a major polymorphic determinant of homocysteine plasma levels and is associated with vascular disease, retesting this trend in additional studies may be worthwhile.
The G allele of Tc2 c.776C ] G leads to the amino acid substitution p.P259R affecting the affinity of Tc2 to vitamin B 12 and the ability to transport vitamin B 12 into tissues [13] [14] [15] . The reported effects on homocysteine levels have been inconsistent [16, 17] . In our sample, the G allele of Tc2 c.766C ] G was associated with higher homocysteine plasma levels in the patient subgroup but not in the whole study population. However, Tc2 c.766C ] G has been reported to be associated with increased methylmalonic acid [17, 18] , which is regarded as a very early indicator of functional vitamin B 12 deficiency. This indicates a reduced intracellular homocysteine remethylation in association with the G allele. Olzewski et al. [19] described a correlation between plasma homocysteine levels and TC as well as TG plasma levels in middle-aged male probands. Treatment with vitamin B 12 , vitamin B 6 , and folic acid over 21 days significantly lowered homocysteine, but also TC, TG, and LDL plasma levels, in these individuals. Recently, it was shown that experimentally induced hyperhomocysteinemia in rats leads to significantly increased plasma cholesterol levels accompanied by an increased expression and activity of hepatic HMGCoA reductase, a rate-limiting enzyme in cholesterol biosynthesis [20] [21] [22] . In addition, it was demonstrated that homocysteine supplementation of yeast leads to an accumulation of S-adenosyl-homocysteine, which attenuates S-adenosyl-methionine-dependent methyltransferase activities and results in an inhibition of phospholipid methylation and finally triacylglycerol accumulation [23] .
Therefore, the association of the G allele of Tc2 c.677C ] G with an unfavorable lipoprotein profile may be explained by a functional vitamin B 12 deficiency and a disturbed intracellular homocysteine and SAM metabolism [1] .
The missing data about family relationship, physical activity, diet, and alcohol consumption are limitations of the present study. However, the results, though preliminary, suggest an intriguing genetic link between homocysteine metabolism and lipoprotein metabolism. Within the limitations of any association study and within the limitations given by the restricted representativity of our study sample concerning the general population, these data support the hypothesis that homocysteine metabolism interacts with lipoprotein metabolism. The missense polymorphism Tc2 c.776C ] G may be a common genetic basis of elevated homocysteine plasma levels and an unfavorable blood lipoprotein profile. The observed biochemical and genetic linkage of homocysteine and lipoprotein plasma levels may be of importance for studies investigating risk factors for vascular disease and should be confirmed in independent studies. 
